Skip to main content

Specialist palliative care until the very end of life - reports of family caregivers and the multiprofessional team



Specialist palliative care (SPC) includes care for incurably ill patients and their family caregivers at home or on a palliative care ward until the very end of life. However, in the last days of life, patients can rarely express their needs and little is known about SPC outcomes as reported by multiprofessional SPC teams and family caregivers.


Using the Palliative Care Outcome Scale (POS; Score 0–40), proxy assessments of SPC outcomes in the patient’s last 3 days of life were performed by SPC teams and primary family caregivers of three home care and three inpatient services. Additional questions were asked about problems solved ‘particularly well’ or ‘inadequately’ (last 7 days), which were content analyzed and quantified.


Proxy assessments by SPC teams were available in 142 patients (of whom 51% had died at home). Family caregiver assessments exist for a subgroup of 60 of these patients. SPC teams (POS total score: mean 13.8, SD 6.3) reported SPC outcomes slightly better than family caregivers (mean 16.7, SD 6.8). The POS items consistently rated as least affected (= 0) by both, SPC teams and family caregivers, were ‘not wasted time’ (team 99%/family caregivers 87%), ‘information’ (84%/47%) and ‘support’ (53%/31%). Items rated as most affected (= 4) were ‘patient anxiety’ (31%/51%), ‘life not worthwhile’ (26%/35%) and ‘no self-worth’ (19%/30%). Both groups indicated more problems solved ‘particularly well’ than ‘inadequately’; the latter concerned mainly clinically well-known challenges during end-of-life care and family caregiver care.


This study shows the range and type of symptoms and other concerns reported in the patient’s last days. Starting points for further improvements in family caregiver care and psychosocial and spiritual issues were identified.

Peer Review reports


Palliative care aims to improve quality of life in patients suffering from incurable, progressive and life-limiting diseases and their family caregivers [1]. Although palliative care focusses mainly on the patients’ quality of life during the often-long disease trajectory, it also includes care towards the end of life including the terminal care for patients in their last days of life. In Germany, specialist palliative care (SPC) can be administered by specialized multiprofessional teams in specific care settings, either as specialist inpatient palliative care on a palliative care ward or as specialist outpatient palliative care (SAPV) at the patient’s home [2]. SAPV is also feasible in patients receiving care in inpatient hospices and nursing homes. SAPV is provided by multiprofessional home palliative care teams, comprising at least specialized physicians and nurses [3].

Patient reported outcome measures (PROMS) are considered standard in clinical practice to ensure adequate patient care during the whole course of SPC [1]. However, the last days in a patient’s life represent a specific situation, as the majority of patients is unable to report their problems and needs themselves. Thus, patient care has to be navigated based on proxy assessments by multiprofessional SPC teams and family caregivers. A longstanding, well-established standard instrument for patient and proxy assessment during SPC is the ‘Palliative Care Outcome Scale’ (POS) [4,5,6,7]; now called the ‘Integrated Palliative Care Outcome Scale’ [8]. End-of-life care has also been evaluated using specific proxy assessment tools like the ‘Quality of Dying and Death Questionnaire’ (QoDD) [9,10,11,12] or the ‘Care of the Dying Evaluation’ (CODE™) [13,14,15] in varying, but mainly non-specialist palliative care settings.

With regard to assessing a dying patient’s symptom burden and needs, differences of family caregivers’ assumptions compared to health care professionals’ assessment may happen: Family caregivers’ subjective experience of the patient’s situation might be influenced by their own anxiety and burden [16, 17] and therefore, they may be less objective proxies than health care professionals are. Health care professionals in turn might underestimate symptom burden or overestimate quality of life as they spend less time with the patient than family caregivers [18, 19]. This dilemma might be mirrored by the heterogeneous results of studies, which mainly, but not consistently report low levels of congruence between the ratings of family caregivers and health care professionals [19,20,21], especially concerning aspects of psychosocial care [21].

Therefore, the aim of our exploratory study was (1) to describe SPC outcomes in the patient’s last days of life from the perspectives of multiprofessional SPC teams and family caregivers. In addition to symptoms and problems assessed by PROM measures, we were interested in subjective accounts on problems that could be solved ‘particularly well’ or remained to be solved ‘inadequately’. Further aims were (2) to compare these two perspectives of SPC teams and family caregivers, and (3) to identify factors associated to SPC outcomes.


Study design and participants

The present study is part of a large prospective, longitudinal, multicenter observational protocol evaluating support needs, psychological problems and personal last wishes of patients during their inpatient and outpatient SPC in the metropolitan area of Hamburg, Germany [22, 23]. This research mainly focused on the patient perspective. To evaluate SPC outcomes until the very end of life, retrospective proxy assessments by adult, primary family caregivers (including family, relatives and friends) and multiprofessional SPC teams were included.

Within the superordinate study, patients were consecutively enrolled in six SPC services of an urban network, including three outpatient SPC services and three palliative care wards between June 2017 and July 2018. The study follow-up period ended in December 2018. Previously trained staff of the participating services recruited patients within 72 h after initiation of SPC. Incurably ill patients were eligible if they were entering in- or outpatient SPC for the first time and were at least 18 years old. Exclusion criteria included cognitive or language limitations, acute critical physical or psychological problems, and imminent death of patients. Additional details on the study design have been described elsewhere [22, 23].

According to the study-protocol, multiprofessional SPC teams completed a questionnaire including the German version of the Palliative Care Outcome Scale (POS) [4,5,6,7] within one week after the patients’ death, if the patient had died in the respective service. SPC teams were instructed that the questionnaire was to be completed by a team member who had personally cared for the patients within the final days of life. Respecting the extraordinary burden in the first weeks after a loved one’s death, family caregivers completed the same questionnaire within 6–8 weeks post-loss. The person, who had been indicated as the primary family caregiver by the patient and had consented to participate in the study, received the questionnaire together with a pre-paid envelope by mail. To comfort the recently bereaved, the study material and a personalized cover letter were sent by the treating SPC team.

The Ethics Committee of the General Medical Council of Hamburg, Germany, approved the study protocol (PV5062). Written informed consent was mandatory for all participating patients and included consent for an assessment post-bereavement by the treating SPC team and the family caregiver indicated by the patient. Additionally, these family caregivers had to sign a written informed consent form for study participation.


The questionnaires for SPC teams and family caregivers included closed and open-ended questions on SPC outcomes in the patient’s last days of life.

The German version of the 3-day recall Palliative Care Outcome Scale (POS) [4,5,6,7] was used for assessment of multidimensional SPC outcomes, as the validation of the later Integrated Palliative Care Outcome Scale (IPOS) – with associated German IPOS – was published in 2019 [8], thus after the data collection period (June 2017 to December 2018). The POS relates to how someone is affected by a symptom or concern. The proxy versions consist of 10 items with 5 response options scoring from 0 (= item rated as least affected) to 4 (= item rated as most affected). The total score ranges from 0 to 40 points, with lower values indicating better outcomes [6]. Additionally, the health care professional version includes a question about the patient’s performance status according to the Eastern Cooperative Oncology Group (ECOG) [24].

In the open part of the questionnaire, two additional questions were asked about problems solved ‘particularly well’ or ‘inadequately’ during the week preceding the patient’s death. These non-validated questions are used in the national German database ‘Hospice and Palliative Care Evaluation’ (HOPE) [25,26,27,28]. In this study, they were added in to the POS measure. SPC teams and family caregivers were asked: ‘Which problems could be solved particularly well during the last 7 days of the patient’s life?’ and ‘Which problems could only be solved ‘inadequately’ during the last 7 days of the patient’s life?’. As literature gives reason to believe that large answer spaces for open-ended questions are likely to improve the quality of responses [29], answer spaces of several lines were designed.

In addition, the SPC teams reported about the patient’s dying situation in terms of location at death (home, inpatient hospice, nursing home, and SPC ward), SPC setting (outpatient vs. inpatient), vigilance status in the last 3 days of the patient’s life, and whether somebody was with the patient at the moment of death.

Data on patients’ socio-demographic, disease- and care-related characteristics were retrieved from the superordinate study database.

Statistical analysis

Descriptive data are reported in frequency and proportions for categorical variables, and means (with standard deviation) for continuous variables. We calculated mean paired differences in POS items and the POS total score at a group level (SPC teams vs. family caregivers) using paired t-tests.

To estimate the agreement and correlations of ratings of categorized POS items, weighted Cohen’s kappa (κw) and Spearman’s rho (rs) were calculated. According to Landis and Koch (1977), kappa should be 0.61–0.80 in order to assume a substantial agreement [30]. According to the benchmarks of Cohen, rs ≥ 0.50 represents large, rs ≥ 0.30 medium, and rs ≥ 0.1 small effects [31]. To reduce complexity, the 5 response options of the POS items were categorized into three groups for these analyses. Categorization was conducted according to Bausewein et al. [6]: category 1 comprises the most positive answer (0 = item rated as least affected), category 2 ratings with 1 or 2, category 3 the most negative answer (3 and 4; 4 = item rated as most affected).

Factors potentially associated with SPC outcomes were analyzed using multivariable linear regression (enter method), with the POS total score being the dependent variable. Independent variables with more than two categories were dichotomized with values of 0 and 1. Possible multicollinearity of independent variables was tested by correlational analysis (Spearman’s r), variance inflation factors (VIFs) and tolerance indices (TIs). For the standardized coefficient ß, effect sizes between 0.10 and 0.29 are small, effect sizes between 0.30 and 0.49 are medium, and effect sizes of 0.50 or greater are large effects [31].

Regarding problems solved ‘particularly well’ and ‘inadequately’, free-text responses of SPC teams and family caregivers were examined by inductive content analysis. Qualitative content analysis is suitable for identifying common issues mentioned in data and measuring the frequency of different categories [32, 33]. For quantifying categories, categories were coded for the presence or absence by assigning a value of 0 (no) or 1 (yes). Frequencies were calculated on person-level as percentages of persons with at least one written account referring to the respective category.

We used the STROBE statement for improving the quality of reporting observational studies [34].


Within the data collection period (June 2017 to December 2018), 193 of 425 participating patients (45%) had died in care of the six participating SPC services. Proxy assessments of SPC teams that conform to the study protocol were available in 142 of these patients (74%). Additionally, family caregiver assessments were existent in a subgroup of 60 of these patients (31%).


On the time of first entering SPC, the mean age of the 142 patients was 71.3 years (range 29–94), 57% were male, about 90% presented with malignant diseases, and 51% had initially entered outpatient SPC. On average, patients died after a mean of 53.7 days (range 0-279) following initiation of SPC. The observed number of transfers between the inpatient and outpatient SPC setting (or vice versa) in the course of SPC was mean 0.6 (range 0–8) with 32% having experienced at least one of such transfers. Dying at home with outpatient SPC was observed in 51% of patients. Details are presented in Table 1.

Table 1 Patient characteristics, care and dying situation (N = 142)

SPC outcome in the patient’s last days of life as reported by SPC teams and family caregivers

The SPC outcome in the patient’s last three days of life (POS total score) was rated better by SPC teams with average 13.8 of 40 points (N = 142, SD 6.3, range: 0–30) compared to family caregivers with average 16.7 points (N = 60, SD 6.8, range: 3–31; data not shown). In a sub-cohort of paired SPC teams and family caregivers (N = 60), the mean POS total scores were nearly identical and differed significantly between SPC teams and family caregivers (p = .039; see Supplement File 1, Table S1).

POS items reported as least affected (rating = 0) were similar between the multiprofessional teams (N = 142) and family caregivers (N = 60), yet differed in their proportion of frequency. These were ‘not wasted time’ with 99% in SPC teams and 87% in family caregivers, ‘information’ in 84% and 47%, and ‘support’ in 53% and 31%. Items reported as most affected (= 4) by both groups were ‘patient anxiety’ with 31% in SPC teams and 51% in family caregivers, ‘life not worthwhile’ in 26% and 35%, and ‘no self-worth’ in 19% and 30%. Detailed data on the SPC teams and family caregiver ratings on the ten POS items are displayed in Table 2.

Table 2 Proxy assessments of SPC teams (N = 142) and family caregivers (N = 60): POS items

In the matched data pairs analysis (N = 60), mean scores of POS items differed significantly between SPC teams and family caregivers for ‘family anxiety’, ‘information’, and ‘support’. For all these symptoms, family caregivers perceived poorer outcomes than SPC teams (p = .001 to p = .010; see Supplement File 1, Table S1).

Agreement and correlation between family caregiver and team assessments

Table 3 presents Cohen’s weighted kappa and Spearman’s rho for correlation between paired SPC teams and family caregivers proxy assessments (N = 60) of the categorized POS items. In this sub-cohort, prevalence of some items differed clinically relevantly (defined as > 10% difference) between SPC teams and family caregivers. Concerning items rated as most affected (rating = 3–4), these were: ‘family anxiety’ (SPC teams: 53%, family caregivers: 80%), ‘support’ (21%/45%), and ‘patient anxiety’ (36%/28%). With regard to items rated as least affected (= 0), ‘information’ (84%/49%), ‘support’ (53%/31%), ‘life not worthwhile’ (17%/29%), and ‘not wasted time’ (99%/88%) showed a clinically relevant difference. These data show that SPC teams’ assessments are more favorable for most symptoms and concerns, but not for all. The full report of categorized proxy assessments is presented as Supplementary Material (see Supplement File 1, Table S2). We observed significant correlations between the assessments of SPC teams and family caregivers concerning ‘pain’ (rs = 0.357, p = .006), ‘other symptoms’ (rs = 0.271, p = .041) and ‘family anxiety’ (rs = 0.314, p = .018) with small to moderate effects. For all other items, no significant correlation could be observed. Except fair agreement for ‘pain’ (κw = 0.259, p = .007), ‘other symptoms‘ (κw = 0.252, p = .013) and ‘family anxiety’ (κw = 0.218, p = .019), concordance of ratings ranged between poor and slight agreement.

Table 3 Agreement and correlation between proxy assessments of family caregivers and SPC teams (paired N = 60)

Factors associated to the proxy assessment of SPC teams

We analyzed the impact of patient-related demographic, disease- and care-related factors as well as the dying situation on SPC outcomes as reported by SPC teams (dependent variable: POS total score, with higher scores representing worse SPC outcomes). Findings of multiple linear regression analysis are reported in Table 4. As highest VIF was 1.91, we concluded that multicollinearity was not a problem in our study [35]. The regression model explained 28.8% of variance in levels of POS total scores and three predictive factors emerged. In order of magnitude these were: patient age, disease type and location at death. Patient age had the largest effect, with younger age significantly predicting worse SPC outcomes (ß = -0.262, p = .001). Dying from a malignant disease showed a significant advantage for SPC outcomes over non-malignant diseases (ß = -0.236, p = .003). Further, dying at home showed a significant advantage for SPC outcomes over not dying at home (ß = 0.243, p = .006). As estimated by the regression, a hypothetical older patient with a malignant disease who died at home could expect better SPC outcome as measured by the POS proxy-version for teams. According to Cohen’s classification of effect sizes, all effects are small [31].

Factors influencing family caregivers’ reports of SPC outcomes in the patient’s last days of life could not be analyzed due to the limited number of available assessments.

Table 4 Factors associated to the SPC teams’ reports of SPC outcomes (N = 142)

Problems solved ‘particularly well’ or ‘inadequate’ in the patient’s last days of life

Qualitative analysis of free-text answers and subsequent quantification revealed more ‘particularly well’ than ‘inadequately’ solved problems within the patients’ last 7 days of life. While ‘particularly well’ solved problems were reported by SPC teams in 112 of 142 cases (78.9%) and by family caregivers in 39 of 60 cases (65.0%), ‘inadequately’ solved problems were stated in 53 of 142 cases (37.3%) and 25 of 60 cases (41.7%), respectively (data not shown).

Main categories of ‘particularly well’ solved problems from the SPC team perspective (N = 112) were physical problems (at least one of such problem indicated in 54%), followed by care-related problems (18%), psychosocial problems (22%), and family caregiver-related problems. Family caregivers’ main categories of ‘particularly well’ solved problems (N = 39) related to physical problems (62%), psychosocial problems (28%), and care-related problems (18%).

Regarding ‘inadequately’ solved problems, main categories among SPC teams (N = 53) related to physical problems (at least one of such problem indicated in 36%), family caregiver-related problems (34%), care-related problems (21%), and psychosocial problems (19%). From the family caregiver perspective (N = 25), main categories of ‘inadequately’ solved problems were physical problems (64%), care-related problems (16%), psychosocial problems (12%) and family caregiver-related problems (12%).

Details on qualitative analyses including subcategories and illustrative quotes as well as quantification of (sub-)categories are presented in Table 5 for SPC teams and in Table 6 for family caregivers.

Table 5 Qualitative analysis of free-text answers from specialized palliative care teams on ‘particularly well’ and ‘inadequately’ solved problems
Table 6 Qualitative analysis of free-text answers from family caregivers on ‘particularly well’ and ‘inadequately’ solved problems


Our study aimed to explore SPC outcomes in the patient’s last days of life from the perspectives of SPC teams and family caregivers. The study demonstrates the range and type of symptoms and other concerns reported in patients’ last days.

Overall, the reported SPC outcome, as reflected by the multidimensional POS total score, was slightly better in SPC teams than in family caregivers. Across both perspectives, POS items rated as least affected related to no waste of time, patient information and support in terms of patient’s ability to share feelings. However, satisfaction rates were consistently lower in family caregivers. Most strikingly, satisfaction with patient information was prevalent in two-thirds of SPC teams, but only in half of family caregivers. Although still one of the aspects rated as least affected, lower ratings may rather mirror family caregivers’ own dissatisfaction with the type, volume or timing of information in the last days of the patient’s life than dissatisfaction of the patient him- or herself. During SPC and as death approaches, family caregivers’ need for information remains high, but seems less met within the patient’s last 7 days of life compared to the beginning of inpatient SPC [36].

Items congruently rated as most affected by both groups related to patient anxiety, patients feeling regarding worthiness of life (‘life not worthwhile’), and patients feeling good about themselves (‘no self-worth’). Prevalence of such ratings were each higher in family caregivers than in SPC teams. These items reflect emotional aspects of end-of-life situations, and evidence points out that psychological symptoms and problems related to the patient’s well-being may be overestimated by family caregivers [17]. Caring for a loved one lasts until his/her death, which is a highly demanding and sometimes overwhelming situation for family caregivers [37]. Uncertainty or worries regarding the emotionality of the patient may affect family caregivers own psychological well-being. Thus, emotional support for family caregivers in terms of being listened to, cared for and empathized with, as well as compassionate communication about their estimates of the patient’s emotionality, are paramount.

Although based on a small-scale subgroup of 60 patients, our findings suggest that the correlation and agreement between proxy assessments of SPC teams and family caregivers was rather low, with family caregiver scores usually indicating poorer outcome. Correlational effects for problems related to pain, other symptoms and family anxiety were small to moderate; however, using weighted kappa (κw) statistics, substantial agreement as defined by Landis and Koch [30] was not found in any of the given problems. This is consistent with the existing literature, mainly reporting discrepancies in family caregivers’ and health care professionals’ assessments of SPC outcome [19, 21, 38]. Empirical evidence indicates that agreement between family caregivers and health care professionals seems best for physical aspects of end-of-life care, especially for pain [19], while agreement for psychological aspects is low [21]. A study that also used the POS for comparing symptom assessment of nurses and family caregivers showed the latter to be more reliable proxies, but both groups tended to overestimate patient’s psychological symptoms [19]. A further study confirmed that nurses and family caregivers overestimated psychological, functional, and existential symptoms compared to patients’ self-reports, but underestimated physical and social symptoms [38]. Our findings hold several potential clinical impacts: Firstly, health care professionals should be aware of the low levels of agreement between professional and family caregiver respondents’ estimations of patients’ SPC outcomes and of how any misperceptions or differences in perspective might affect the family or patient. For example, differences might manifest in conflict when family caregivers are disappointed because they feel that the SPC team does not take the patient’s problems and needs seriously. Secondly, more communication about end-of-life issues between SPC teams and family caregivers should be encouraged, particularly with regard to psychological aspects. Beyond benefits of shared perspectives for the patient’s care and comfort during his/her last days of life, family caregivers’ perceptions of the patients dying are key for their own well-being and their grieving process [39, 40]. Lastly, notwithstanding, the patient’s self-assessment is imperative, but patient’s ability to report symptoms may diminish as illness progresses and the need for proxy responders sometimes arises. Nonetheless, a study on routinely collected PROMs in palliative care showed that in most clinical scenarios patient-provided self-reports are feasible [41]. Training and guidance for health care professionals in palliative care on how to implement and support patient- (and proxy-)reported outcomes could improve the use of PROMs [42]. If proxy-assessment is due, our findings – together with the existing evidence – highlight the need to consider both the family caregiver and the health care professional perspective when caring for a dying patient.

Further, we were interested in identifying factors associated with the reported SPC outcome in the patient’s last days of life, as reflected by the POS total score. While we waived respective analysis for family caregiver assessments due to the limited amount of data, multivariable regression analysis was feasible in SPC teams. We found younger patient age, a non-malignant disease and not having died at home to be predictors of worse SPC outcomes. In line with our results, studies repeatedly report dying at home to predict better quality of death and dying [9, 43]. With regard to patients who had died from a non-malignant disease, evidence shows that patients are less likely to be aware of their prognosis, are more likely to have unmet palliative care needs, and access SPC services often late in the disease trajectory [44,45,46]. These aspects may add complexity to SPC for patients with non-malignant diseases and may negatively affect SPC outcomes in the patient’s last days of life as reported by SPC teams. As for the impact of age, it is well known that care delivery for younger people dying from incurable illnesses imposes a specific burden to health care professionals [47], which may shape SPC teams’ critical reports on SPC outcomes in the patient’s last days of life. However, more research is warranted to gain a better understanding on the relationship of SPC outcome as assessed by SPC teams and patient age.

Navigating the dying days is challenging to both SPC teams and family caregivers. However, our analysis of problems solved ‘particularly well’ shows that SPC seems to address the main problems patients face in their last days of life. Problems solved ‘inadequately’ were less often reported, but covered the full range of challenging problems in end-of-life care. Particularly, written accounts point out room for improvement regarding family caregiver care and the psychosocial and spiritual dimension of palliative care in the patient’s last days of life. This is in line with a previous study, which also identified insufficient professional support for informal caregivers and inadequate psychosocial support for patients as unsolved problems [48]. Our findings underline the unique, complex and multilayered situation when life ends, as problems of similar nature were encountered as problems solved ‘particularly well’ as well as ‘inadequately’.


The relatively small numbers of family caregivers, who completed the assessment post-bereavement, limits our study. Unfortunately, we lack reliable knowledge about the proportion of potentially eligible family caregivers among the 142 studied patients. Thus, we cannot estimate non-responder analyses and can only report on a convenience sample. Further, over 90% of participants presented with an oncological disease. In Germany, the majority of patients in SPC services are cancer patients [49]. Yet, given that SPC’s embracing approach includes all people with a life-limiting disease, this can be another limitation. Lastly, the examination of agreement between SPC teams and family caregivers based on categorized POS items scores [6]. That is, the most positive answer was left in its own category, while the other response options were collapsed into two new categories. A different categorization scheme, leaving the midpoint in its own category, might have resulted in more balanced categories.


The study demonstrates the range of symptoms and other concerns occurring in the patient’s last days. Overall, care seems to be perceived as adequate until the very end of patients’ lives according to proxy assessments. However, our study revealed that improvements in family caregiver care and psychosocial and spiritual issues may benefit high quality SPC until the patient’s death. Proxy measures should be implemented when the patient’s health deteriorates to ensure systematic assessment of problems and concerns. Close communication between family caregivers and SPC teams is paramount during the patient’s last days of life in order to address his/her needs in the best possible way, as agreement by proxies was low for most symptoms and problems. Reasons for low agreement of health care professionals and family caregivers deserve further research and awareness in daily clinical practice. Further, future research should focus on factors related to family caregivers’ reports of SPC outcomes in the patient’s last days of life and compare those to factors associated with the reports of SPC teams.

Data Availability

The datasets generated and/or analyzed during the current study are not publicly available, but are available from the corresponding author (AU) on reasonable request and with authorization of the data protection officer of the University Medical Center Hamburg-Eppendorf, Hamburg, Germany.



Care of the Dying Evaluation


Eastern Cooperative Oncology Group


Hospice and Palliative Care Evaluation


Integrated Palliative Care Outcome Scale


Palliative Care Outcome Scale


Patient reported outcome measures


Quality of Dying and Death Questionnaire


Specialist palliative care


Tolerance indices


Variance inflation factor


  1. World Health Organization. WHO definition of palliative care; 2002. (accessed 30.05.2022).

  2. Wikert J, Gesell D, Bausewein C, Jansky M, Nauck F, Kranz S, Hodiamont F. Specialist palliative care classification: typology development. BMJ Support Palliat Care 2022 [online ahead of print].

  3. Freytag A, Krause M, Bauer A, Ditscheid B, Jansky M, Krauss S, Lehmann T, Marschall U, Nauck F, Schneider W, et al. Study protocol for a multi-methods study: SAVOIR - evaluation of specialized outpatient palliative care (SAPV) in Germany: outcomes, interactions, regional differences. BMC Palliat Care. 2019;18(1):12.

    PubMed  PubMed Central  Google Scholar 

  4. Hearn J, Higginson IJ. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care. 1999;8(4):219–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Rugno FC, Carlo MM. The Palliative Outcome Scale (POS) applied to clinical practice and research: an integrative review. Rev Lat Am Enfermagem. 2016;24:e2764.

    PubMed  PubMed Central  Google Scholar 

  6. Bausewein C, Fegg M, Radbruch L, Nauck F, von Mackensen S, Borasio GD, Higginson IJ. Validation and clinical application of the german version of the palliative care outcome scale. J Pain Symptom Manage. 2005;30(1):51–62.

    PubMed  Google Scholar 

  7. Bausewein C, Le Grice C, Simon S, Higginson I. The use of two common palliative outcome measures in clinical care and research: a systematic review of POS and STAS. Palliat Med. 2011;25(4):304–13.

    CAS  PubMed  Google Scholar 

  8. Murtagh FE, Ramsenthaler C, Firth A, Groeneveld EI, Lovell N, Simon ST, Denzel J, Guo P, Bernhardt F, Schildmann E, et al. A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS). Palliat Med. 2019;33(8):1045–57.

    PubMed  PubMed Central  Google Scholar 

  9. Gutiérrez-Sánchez D, Gómez-García R, Roselló MLM, Cuesta-Vargas AI. The quality of dying and death of advanced cancer patients in palliative care and its association with place of death and quality of care. J Hosp Palliat Nurs. 2021;23(3):264–70.

    PubMed  Google Scholar 

  10. Hales S, Gagliese L, Nissim R, Zimmermann C, Rodin G. Understanding bereaved caregiver evaluations of the quality of dying and death: an application of cognitive interviewing methodology to the quality of dying and death questionnaire. J Pain Symptom Manage. 2012;43(2):195–204.

    PubMed  Google Scholar 

  11. Heckel M, Bussmann S, Stiel S, Ostgathe C, Weber M. Validation of the german version of the quality of Dying and Death Questionnaire for Health Professionals. Am J Hosp Palliat Care. 2016;33(8):760–9.

    PubMed  Google Scholar 

  12. Heckel M, Bussmann S, Stiel S, Weber M, Ostgathe C. Validation of the german version of the quality of Dying and Death Questionnaire for Informal Caregivers (QODD-D-Ang). J Pain Symptom Manage. 2015;50(3):402–13.

    PubMed  Google Scholar 

  13. Heckel M, Vogt AR, Stiel S, Radon J, Kurkowski S, Goebel S, Ostgathe C, Weber M. The quality of care of the dying in hospital-next-of-kin perspectives. Support Care Cancer. 2020;28(9):4527–37.

    PubMed  PubMed Central  Google Scholar 

  14. Mayland CR, Gerlach C, Sigurdardottir K, Hansen MIT, Leppert W, Stachowiak A, Krajewska M, Garcia-Yanneo E, Tripodoro VA, Goldraij G, et al. Assessing quality of care for the dying from the bereaved relatives’ perspective: using pre-testing survey methods across seven countries to develop an international outcome measure. Palliat Med. 2019;33(3):357–68.

    PubMed  PubMed Central  Google Scholar 

  15. Vogt A, Stiel S, Heckel M, Goebel S, Mai SS, Seifert A, Gerlach C, Ostgathe C, Weber M. Assessment of the quality of end-of-life care: translation and validation of the german version of the care of the dying evaluation (CODE-GER) - a questionnaire for bereaved relatives. Health Qual Life Outcomes. 2020;18(1):311.

    PubMed  PubMed Central  Google Scholar 

  16. Oechsle K, Goerth K, Bokemeyer C, Mehnert A. Anxiety and depression in caregivers of terminally ill cancer patients: impact on their perspective of the patients’ symptom burden. J Palliat Med. 2013;16(9):1095–101.

    PubMed  Google Scholar 

  17. Tang ST, McCorkle R. Use of family proxies in quality of life research for cancer patients at the end of life: a literature review. Cancer Invest. 2002;20(7–8):1086–104.

    PubMed  Google Scholar 

  18. Oechsle K, Goerth K, Bokemeyer C, Mehnert A. Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians. Support Care Cancer. 2013;21(7):1955–62.

    PubMed  Google Scholar 

  19. Dawber R, Armour K, Ferry P, Mukherjee B, Carter C, Meystre C. Comparison of informal caregiver and named nurse assessment of symptoms in elderly patients dying in hospital using the palliative outcome scale. BMJ Support Palliat Care. 2019;9(2):175–82.

    PubMed  Google Scholar 

  20. Stiel S, Heckel M, Wendt KN, Weber M, Ostgathe C. Palliative Care Patients’ quality of dying and circumstances of death-comparison of Informal Caregivers’ and Health-Care Professionals’ estimates. Am J Hosp Palliat Care. 2018;35(7):1023–9.

    PubMed  Google Scholar 

  21. Cheng SY, Dy S, Huang SB, Chen CY, Chiu TY. Comparison of proxy ratings of main family caregivers and physicians on the quality of dying of terminally ill cancer patients. Jpn J Clin Oncol. 2013;43(8):795–804.

    PubMed  Google Scholar 

  22. Ullrich A, Schulz H, Goldbach S, Hollburg W, Rommel A, Müller M, Kirsch D, Kopplin-Förtsch K, Messerer J, König L, et al. Need for additional professional psychosocial and spiritual support in patients with advanced diseases in the course of specialist palliative care - a longitudinal observational study. BMC Palliat Care. 2021;20(1):182.

    PubMed  PubMed Central  Google Scholar 

  23. Ullrich A, Hollburg W, Schulz H, Goldbach S, Rommel A, Müller M, Kirsch D, Kopplin-Foertsch K, Messerer J, König L, et al. What are the personal last wishes of people with a life-limiting illness? Findings from a longitudinal observational study in specialist palliative care. BMC Palliat Care. 2022;21(1):38.

    PubMed  PubMed Central  Google Scholar 

  24. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

    CAS  PubMed  Google Scholar 

  25. Ostgathe C, Gaertner J, Kotterba M, Klein S, Lindena G, Nauck F, Radbruch L, Voltz R. Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer. 2010;18(9):1157–63.

    PubMed  Google Scholar 

  26. Ostgathe C, Alt-Epping B, Golla H, Gaertner J, Lindena G, Radbruch L, Voltz R. Non-cancer patients in specialized palliative care in Germany: what are the problems? Palliat Med. 2011;25(2):148–52.

    PubMed  Google Scholar 

  27. Alt-Epping B, Pache S, Lindena G, Nauck F. Anticancer therapies in specialized palliative care–a multicenter survey. Support Care Cancer. 2012;20(10):2385–9.

    CAS  PubMed  Google Scholar 

  28. Alt-Epping B, Stäritz AE, Simon ST, Altfelder N, Hotz T, Lindena G, Nauck F. What is special about patients with lung cancer and pulmonary metastases in palliative care? Results from a nationwide survey. J Palliat Med. 2012;15(9):971–7.

    PubMed  Google Scholar 

  29. Israel GD. Effects of answer space size on responses to open-ended questions in mail surveys. J Official Stat. 2010;26(2):271.

    Google Scholar 

  30. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.

    CAS  PubMed  Google Scholar 

  31. Cohen J. Statistical power analysis for the behavioral Sciences. New York, NY: Routledge Academic; 1988.

    Google Scholar 

  32. Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398–405.

    PubMed  Google Scholar 

  33. Green J, Thorogood N. Analysing qualitative data. In: Qualitative methods for health research (1st edn) Edited by Silverman D. London: Sage Publications; 2004: 173–200.

  34. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.

    Google Scholar 

  35. Mansfield ERHB. Detecting multicollinearity. Am Stat. 1982;36:158–60.

    Google Scholar 

  36. Ullrich A, Marx G, Bergelt C, Benze G, Zhang Y, Wowretzko F, Heine J, Dickel L-M, Nauck F, Bokemeyer C, et al. Supportive care needs and service use during palliative care in family caregivers of patients with advanced cancer: a prospective longitudinal study. Support Care Cancer. 2021;29(3):1303–15.

    PubMed  Google Scholar 

  37. Payne S, Grande G. Towards better support for family carers: a richer understanding. Palliat Med. 2013;27(7):579–80.

    PubMed  Google Scholar 

  38. Van Lancker A. Symptom assessment in hospitalized older palliative patients with cancer: agreement among patients, nurses, and proxies. Oncol Nurs Forum. 2015;42(2):E73–E90.

    PubMed  Google Scholar 

  39. Chen C, Du L, Wu Q, Jin Y. Family caregivers’ perceptions about patients’ dying and death quality influence their grief intensity. Appl Nurs Res. 2021;62:151456.

    PubMed  Google Scholar 

  40. Mah K, Swami N, Pope A, Earle CC, Krzyzanowska MK, Nissim R, Hales S, Rodin G, Hannon B, Zimmermann C. Caregiver bereavement outcomes in advanced cancer: associations with quality of death and patient age. Support Care Cancer 2021:1–11.

  41. Clapham S, Daveson BA, Allingham SF, Morris D, Blackburn P, Johnson CE, Eagar K. Patient-reported outcome measurement of symptom distress is feasible in most clinical scenarios in palliative care: an observational study involving routinely collected data. Int J Qual Health Care 2021, 33(2).

  42. Bausewein C, Simon ST, Benalia H, Downing J, Mwangi-Powell FN, Daveson BA, Harding R, Higginson IJ. Implementing patient reported outcome measures (PROMs) in palliative care–users’ cry for help. Health Qual Life Outcomes. 2011;9:27.

    PubMed  PubMed Central  Google Scholar 

  43. Hales S, Chiu A, Husain A, Braun M, Rydall A, Gagliese L, Zimmermann C, Rodin G. The quality of dying and death in cancer and its relationship to palliative care and place of death. J Pain Symptom Manage. 2014;48(5):839–51.

    PubMed  Google Scholar 

  44. Stiel S, Heckel M, Seifert A, Frauendorf T, Hanke RM, Ostgathe C. Comparison of terminally ill cancer- vs. non-cancer patients in specialized palliative home care in Germany – a single service analysis. BMC Palliat Care. 2015;14(1):34.

    PubMed  PubMed Central  Google Scholar 

  45. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med. 2001;15(4):287–95.

    CAS  PubMed  Google Scholar 

  46. Chou WC, Lai YT, Huang YC, Chang CL, Wu WS, Hung YS. Comparing end-of-life care for hospitalized patients with chronic obstructive pulmonary disease and lung cancer in Taiwan. J Palliat Care. 2013;29(1):29–35.

    PubMed  Google Scholar 

  47. Kenten C, Ngwenya N, Gibson F, Flatley M, Jones L, Pearce S, Wong G, Black KM, Haig S, Hough R, et al. Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals. BMJ Open. 2019;9(1):e024397–7.

    PubMed  PubMed Central  Google Scholar 

  48. Knop J, Dust G, Kasdorf A, Schippel N, Rietz C, Strupp J, Voltz R. Unsolved problems and unwanted decision-making in the last year of life: a qualitative analysis of comments from bereaved caregivers. Palliat Support Care. 2023;21(2):261–9.

    Google Scholar 

  49. Hess S, Stiel S, Hofmann S, Klein C, Lindena G, Ostgathe C. Trends in specialized palliative care for non-cancer patients in Germany–data from the national hospice and palliative care evaluation (HOPE). Eur J Intern Med. 2014;25(2):187–92.

    PubMed  Google Scholar 

Download references


The authors wish to thank all participating teams and family caregivers for sharing their experience.


Open Access funding enabled and organized by Projekt DEAL. We acknowledge financial support from the Open Access Publication Fund of UKE - Universitätsklinikum Hamburg-Eppendorf and DFG - German Research Foundation. This study received funding by the German Cancer Aid (‘Deutsche Krebshilfe e.V.’, grant number 70112144). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations



Conceptualization: KO, HS; Methodology: AU; Validation: AU, KO; Formal analysis: AU; Investigation: AU, SG, WH, BW, AR, MM, DK, KKF; Resources: SG, WH, BW, AR, MM, DK, KKF, KO, CB; Data Curation: AU; Writing – Original Draft: AU, KO; Writing – Review & Editing: all authors; Visualization: AU; Supervision: AU, HS, KO; Project administration: AU; Funding Acquisition: KO, HS.

Corresponding author

Correspondence to Anneke Ullrich.

Ethics declarations

Competing interests

The authors have no competing interests to declare that are relevant to the content of this article.

Ethics approval and consent to participate

This study was conducted in accordance with the Helsinki Declaration of 1975 as revised in 2008. The ethics committee of the General Medical Council of Hamburg, Germany, approved the study protocol (reference number PV5062). All participants provided written informed consent including study participation, data analysis and publication.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ullrich, A., Goldbach, S., Hollburg, W. et al. Specialist palliative care until the very end of life - reports of family caregivers and the multiprofessional team. BMC Palliat Care 22, 153 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: